The increased binds of CXCL1 or CXCL2 to CXCR2 leads to reduced SAP18 expression under tumor conditions, which subsequently activates the ERK/STAT3 signaling pathway to promote mo-MDSCs accumulation (Fig. 7). This evidence concerns the gene CXCR2 and neoplasm.